A rare case of disseminated amebiasis in a patient on biologic therapy for chronic rhinosinusitis
Dupilumab targets Th2-associated inflammatory mediators to reduce disease burden in CRSwNP. While rare, potential sequelae include viral, helminth, and potentially amebic infections.
Authors
- Ariel Omiunu (ORCID: https://orcid.org/0000-0001-7876-7883)
- R. Peter Manes (ORCID: https://orcid.org/0000-0003-3180-7467)
- Darpan Kayastha
- Lindsey Brown (ORCID: https://orcid.org/0000-0002-7652-8421)
Institutions
- Yale University (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1002/alr.23473
- Citations
- 1
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.58